Search

Author/Creator Vyas, Shefali

1. 352 Efficacy and safety of abrocitinib in Chinese patients with moderate-to-severe atopic dermatitis: a post-hoc analysis of the JADE REGIMEN phase 3 trial. (25th January 2023)

Authors:
Li, Hang; Cheng, Hao; Lu, Qianjin; Lai, Wei; Tao, Xiaohua; Encinas, Gerardo A; Vyas, Shefali; Wang, Bo; Luo, Xin; Li, Shiqi
Journal:
British journal of dermatology
Issue:
Volume 188(2023)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Patient Recruitment into a Multicenter Randomized Clinical Trial 
for Kidney Disease: Report of the Focal Segmental Glomerulosclerosis Clinical Trial (FSGS CT). Issue 1 (30th October 2012)

Authors:
Ferris, Maria; Norwood, Victoria; Radeva, Milena; Gassman, Jennifer J.; Al‐Uzri, Amira; Askenazi, David; Matoo, Tej; Pinsk, Maury; Sharma, Amita; Smoyer, William; Stults, Jenna; Vyas, Shefali; Weiss, Robert; Gipson, Debbie; Kaskel, Frederick; Friedman, Aaron; Moxey‐Mims, Marva; Trachtman, Howard
Journal:
Clinical and translational science
Issue:
Volume 6:Issue 1(2013)
Page Start:
13
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗